• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 19-Jan-2021 EOD, Market Closed
49,398.29
834.02 (1.72%)
NIFTY
14,521.15
239.85 (1.68%)
SENSEX
    No Companies Visited

Back to news list
  • Gland Pharma IPO subscribed 4%

    The issue received bids for 12.69 lakh shares as against 3.02 crore shares on offer.

    The initial public offer (IPO) of Gland Pharma received bids for 12.69 lakh shares on Monday, 9 November 2020, as against 3.02 crore shares on offer, as per the National Stock Exchange of India (NSE) website data at 17:00 IST. The issue was subscribed 0.04 times.

    The issue opened for bidding today, 9 November 2020 and it will close on Wednesday, 11 November 2020. The price band for the IPO is set at Rs 1490-1500 per share.

    The IPO consists of fresh issue of shares amounting to Rs 1250 crore and an offer of sale of 3,48,63,635 shares by the selling shareholders.

    Ahead of the IPO, the Hyderabad-based generic injectables-focused company allotted 1,29,59,089 shares to 70 anchor investors at Rs 1,500 per share aggregating to Rs 1,943.86 crore.

    Overseas investors included SmallCap World Fund INC, Government of Singapore, The Nomura Trust And Banking Co and Goldman Sachs.

    Out of the total 1,29,59,089 shares allotted to anchor investors, the company allocated 43,19,700 shares (or 33.33% of the total anchor allotment portion) to 18 domestic mutual funds through a total of 77 schemes.

    The proceeds of the offer for sale shall be received by the selling shareholders. The company proposes to utilise the net proceeds of the fresh issue towards funding incremental working capital requirements; funding capital expenditure requirements; and general corporate purposes.

    The company recorded net profit of Rs 313.59 crore and total income of Rs 916.28 crore in the quarter ended on 30 June 2020.

    Hyderabad-based Gland Pharma is one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. It operates primarily under a business to business (B2B) model and it engaged in development, manufacturing and marketing of complex injectables. The company is promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

    Back to news list
Previous Stories :
More

Quick Links

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
91-22-25230011
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 19-Jan-2021
  •  ( 17:41) IRFC IPO subscribed 1.22 times  
  •  ( 17:28) CEAT Q3 PAT up 150.31% YoY to Rs 132.14 crore   
  •  ( 15:36) Sensex zooms 824 pts, Nifty closes above 14,500  
  •  ( 15:32) Tata Metaliks Q3 PAT up 63.75% Y-o-Y to Rs 75.18 cr  
  •  ( 15:14) Hatsun Agro Products consol. Q3 PAT up 141.42% Y-o-Y to Rs 67.31 cr  
  •  ( 15:12) Man Industries bags new orders worth approximately Rs 250 crore  
  •  ( 15:10) Bank of Maharashtra Q3 PAT up 14% to Rs 154 crore  
  •  ( 15:08) Adani Enterprises three subsidiaries sign concession agreement with AAI  
  •  ( 15:07) CSB Bank gains after Q3 PAT jumps 89% YoY to Rs 53 cr  
  •  ( 15:03) RBL Bank board OKs re-appointment of Vishwavir Ahuja as MD, CEO  
  •  ( 15:02) Alembic Pharmaceuticals reports 25% YoY rise in Q3 PAT  
  •  ( 13:34) India VIX falls almost 5%  
  •  ( 13:33) European markets opens higher, buoyed by positive sentiment  
  •  ( 13:32) Indices continue to hit fresh intraday highs  
  •  ( 12:38) The Nifty index hovered below 14,500 mark  
  •  ( 12:37) Indices at day's high; strong market breadth  
  •  ( 11:53) Indiabulls Real Estate Q3 PAT rises 63% YoY to Rs 80.6 cr  
  •  ( 11:37) Goa Carbon resumes operations at Paradeep unit in Odisha w.e.f Jan. 18  
  •  ( 11:22) Board of L&T Financial Services approves rights issue at Rs 65 a share  
  •  ( 10:38) Escorts secures Budni certification in India for electric tractor  
  •  ( 10:30) Indices at day's high  
  •  ( 10:03) United Drilling Tools to set up a new manufacturing plant in Gujarat   
  •  ( 10:01) Yes Bank board to mull fund raising plans on Jan 22  
  •  ( 09:44) IRB Infra. Developers consol. Q3 PAT down 56.5% Y-o-Y to Rs 69.48 cr  
  •  ( 09:32) Strong market breadth  
  •  ( 09:29) IndiaMART InterMESH Q3 PAT rises 29% YoY to Rs 80 cr  
  •  ( 09:26) Market opens on strong note  
  •  ( 08:21) Asian stocks trading mixed  
Show News
19 January 2021 00:00
2645.60
(2.18 %)
668.50
(1.89 %)
3641.35
(2.27 %)
4960.85
(5.25 %)
8922.40
(6.80 %)
592.50
(0.99 %)
5086.95
(0.68 %)
2654.90
(3.45 %)
983.65
(0.28 %)
1503.40
(1.36 %)
2364.10
(1.31 %)
546.30
(2.64 %)
940.15
(0.99 %)
1317.05
(0.41 %)
218.90
(-0.30 %)
1886.80
(2.05 %)
1369.75
(2.63 %)
808.15
(-0.01 %)
7924.60
(1.41 %)
17755.55
(0.72 %)
99.65
(2.21 %)
98.10
(1.45 %)
199.80
(1.96 %)
2016.30
(1.65 %)
298.60
(1.53 %)
596.25
(2.55 %)
3265.15
(1.38 %)
992.65
(-0.54 %)
1519.95
(1.08 %)
5488.35
(1.80 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.